Vir Biotechnology GAAP EPS of -$0.31 beats by $0.10, revenue of $64.07M beats by $44.16M

Vir Biotechnology announced its fourth-quarter financial results, reporting a GAAP EPS of -$0.31, beating estimates by $0.10, and revenue of $64.07 million, surpassing estimates by $44.16 million.